PRADAXA 150 MG 30 HARD CAPS براداكسا 150 مجم 30 كبسولة


** Pradaxa® (Dabigatran etexilate) 150 mg 30 hard capsules.

** Indications:
– Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF) with one or more risk factors, such as prior stroke or transient ischemic attack (TIA); age >/= 75 years; heart failure (NYHA Class >/= II); diabetes mellitus; hypertension.
– Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.

** Composition:
Each hard capsule contains:
172.95 mg dabigatran etexilate mesilate equivalent to 150 mg dabigatran etexilate.

** Any unused product or waste material should be disposed of in accordance with local requirements.

** Medical products subject to medical prescription.

** Do not chew. Read the package leaflet before use.
Oral use.

** Store below 30 degrees C. Store in the original package in order to protect from moisture.
Keep out of the reach and sight of children.


لا توجد مراجعات بعد.

كن أول من يقيم “PRADAXA 150 MG 30 HARD CAPS براداكسا 150 مجم 30 كبسولة”

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *

Open chat
طلب مساعده ؟
شكرًا على التواصل مع لوميكسا ارسل: 1-العمر,النوع, الوزن 2- الامراض المزمنه